Physician profile
Natalya Davis
NPI 1952342917
$349.39
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.50 · 2020: $34.04 · 2022: $27.90 · 2023: $16.57 · 2024: $38.24 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $75.06 | 2023-2025 | |
| Hologic Sales and Service, LLC | $48.72 | 2022-2025 | Aptima |
| Alk-Abello, INC | $45.08 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $34.01 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $26.92 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $23.04 | 2019 | |
| Lnhc, INC | $21.98 | 2025 | Zelsuvmi |
| Sobi, INC | $19.19 | 2020 | |
| Sanofi Pasteur INC. | $18.71 | 2019 | |
| Shire North American Group INC | $18.35 | 2019 | |
| Kaleo, INC. | $18.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalya Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.